Navigating the Emerging and Evolving Landscape of HER2-Low Breast Cancer

Learn more about HER2 testing and emerging treatment options for patients with HER2-low breast cancer.

For additional education and resources on HER2-low breast cancer including online modules podcasts and downloadable slides visit ASCP&rsquo s website at  https://www.ascp.org/content/learning/breast-cancer.

Share

Program Content

Activities

Understanding HER2-Low Breast Cancer
Understanding HER2-Low Breast Cancer: Current Challenges and Emerging Opportunities for Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 24, 2022

Expires: March 23, 2023

Faculty

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Q Synthesis LLC

ProCE Banner